Jump to content
RemedySpot.com

MS

Rate this topic


Guest guest

Recommended Posts

Guest guest

Treating MS with Antibiotics

This article submitted by Dan Osborne on 7/22/96.

Author's Email: dosborne@...

Thanks again to Danger Alvarez for bringing this up (see " Curing MS w

Antibiotics, a Hoax? 5/2/96). I asked Dr. Lindner some questions via e-mail.

He replied to the questions, and also sent three papers: Experimental

Treatment Protocols for New Bacterium; Nutrition and Lifestyle Suggestions;

and Culture Shipping Information, for shipping blood samples. Following is a

summary of the twenty pages he sent.

Dr. Luther Lindner is a physician (pathologist) on the faculty of Texas A & M

University, College of Medicine. He is studying a bacterium which seems to be

associated with chronic fatigue and immune dysfunction syndrome (CFIDS),

fibromyalgia, and several autoimmune disorders including multiple sclerosis,

lupus erythematosis, and rheumatoid arthritis. Opinion differs on whether

this bacterium is a true spirochete; whether it is or not, it is clearly not

the spirochete which causes Lyme Disease.

This bacterium has been found in essentially all persons tested, both those

with the above maladies, and persons who are healthy. Persons with symptoms

usually have higher levels than healthy persons, but not always. About 100 MS

patients have been tested, and about the same number of CFIDS patients. In

both groups, when a patient has an increase in bacterial level, it

corresponds with worsening symptoms; a lowering of the bacterial level

corresponds with improving symptoms, or a lack of symptoms.

Dr. Lindner does not take patients directly for treatment. He tests blood

samples for the bacterium, he tests the particular strain for response to

various antibiotics, and he will advise your physician on recommended levels

of particular antibiotics. Some strains of the bacterium are resistant to all

currently available antibiotics. As treatment progresses, blood levels should

be periodically checked. The testing of blood samples used to be free, but no

more: it is now $40 US. The antibiotics run about $300 per month. About 20 to

25% of MS patients are greatly helped, and another 25% are helped some. More

than half of the patients are helped very little or not at all. The CFIDS

patients respond somewhat better. A few MS patients seem to have been made

worse by antibiotic treatment.

In medical terms, patients who stop having attacks are not " cured " , they are

only " in remission " . The bacteria are still present in low levels. Nutrition

and lifetyle changes are suggested in order to suppress the bacteria.

In addition to antibiotics, and as an alternative, Dr. Lindner provides

several pages of suggestions for a nutrition and lifestyle approach to

treatment. Certain metals, particularly copper, stimulate bacterial growth

and should be avoided; zinc suppresses growth of these bacteria, and intake

is recommended. Vitamins, herbs, and stuff I had never heard of is discussed.

There are no figures for the percentage of patients helped by these methods.

I asked Dr. Lindner why so little attention has been given to this in the MS

community. He gave several reasons: 1) The initial work is still in progress,

and nothing has been published in any medical journal. 2) Medical dogma says

that there are no bacteria in the bloodstream or the cerebrospinal fluid.

This bacteria is found in those places. 3) Medical dogma also says that MS is

caused by a virus or an autoimmune dysfunction.

Dr. Lindner clearly states that this is an experimental treatment, and any

patient should be fully aware of that fact. Many doctors will not spend time

and money on an experimental treatment.

Medical dogma says that there is no evidence that antibiotics can help MS.

Patient success stories do not constitute evidence. Only controlled studies

are evidence.

For patient success stories, spirochete background, published articles on

bacteria and MS, status of a controlled study on this treatment in

Saskatchewan, and Dr. Lindner's e-mail address, see Grahame 's MS page

at:

http://ourworld.compuserve.com/homepages/G/

Next Article

Previous Article

Return to Topic Menu

------------------------------------------------------------------------------

--

Here is a list of responses that have been posted to this article...

------------------------------------------------------------------------------

--

You now have TWO OPTIONS: Post a new Article or post a Response to this

Article

Click here to post a new Article!

If you would like to post a Response to this article, fill out this form

completely...

Do not use slashes ( " / " ) or colons ( " : " ) or other " special " characters in

your Article title!

Also, please be sure to make your Response Title something descriptive...NOT

the same title as the original article..

Response Title:

Author:

Author Email:

Response Text:

Original Article: (Don't change this field!)

Forum: (Don't change this field either!)

------------------------------------------------------------------------------

--

Article complete. Click HERE to return to the Neurology Web-Forum Menu.

Link to comment
Share on other sites

Guest guest

,

There is a Dr. Roy Swank in Portland, Oregon who has fantastic results in

treating MS. People come from all over the world to see him. I became

aware of this in & Anne Frahm's book, " Reclaim Your Health. " I have

two friends who have MS and I really picked up on this info. The book is not

available at this time, for it is being rewritten/updated, but &

Noble said it would be available again soon.

Dr. Swank has a book, " The Multiple Sclerosis Diet Book. " Also,

Robbins in his book, " Diet for a New America " gives good information re MS

on pages 279-282. Other books referenced in the " Reclaim " book were: " Don't

Drink Your Milk " by A.Oski, M.D.; " It's All in Your Head " by Hal A. Huggins.

D.D.S.; Multiple Sclerosis, A Self-Help Guide to Its Management " by Judy

Graham; " Special Diet Cookbook; Multiple Sclerosis " by Geraldine Fitzgerald

and Fenella Briscoe; and " The Yeast Connection " by G. Crook, M.D.

(See " Does Candida Cause Multiple Sclerosis, Psoriasis, Arthritis or

Schizophrenia? " pages 218-228.

, that ought to keep her busy and informed for a while. Good luck to

you both.

Billie

.

rheumatic MS

>From: arjay <arjay@...>

>

>Does anyone have any info on alternative treatments for MS, one of my

>sisters was just diagnosed with it (she also has bad emphysema) since

>she isn't on the net I told her I'd research it.

>Thanks,

>

>---------------------------

Link to comment
Share on other sites

  • 10 months later...
Guest guest

Here is a web site with a lot of links to this issue, Carol Hope you are

doing well :-)

http://www.google.com/search?q=Antibiotics+multiple+sclerosis & num=10 & meta=hl%3

Den%26lr%3D & safe=off <A

HREF= " http://www.google.com/search?q=Antibiotics+multiple+sclerosis & num=10 & met

a=hl%3Den%26lr%3D & safe=off " >Google Search: Antibiotics multiple sclerosis</A>

Link to comment
Share on other sites

  • 11 months later...
Guest guest

Dear Debb,

I am not sure if this is of any help, but I have lots of similar symptoms to M.S. but my M.R.I. scans show everything looks normal. The doctors say mine is definately not M.S. because of the scan results. Have you had an M.R.I? All my doctors can come up with is Chronic Fatigue Syndrome and Fibromayalgia. Frustrating isn't it?!!!!

Rosemary.

allrosy@...

rheumatic MS

Hi, Hoping someone can help me, a Dr did extensive blood work on me and then did not explain much of it..I noticed in the copies he gave me that it is noted I have high myelin sheath deteriotion that occurs in MS..yet this DR was more concerned with the accompanying virus's, Epstein Barr, CMV and HH6..I did a little research and found that HH6 occurs in 1/3 of patients with MS..The Alternative MD who did the blood, when asked if I had MS, said he did not know...anyone with any info? thanks, DEBB To unsubscribe, email: rheumatic-unsubscribeegroups

Link to comment
Share on other sites

Guest guest

Hi Debb, Rosemary, & everyone--

A while back a few people in the group emailed me saying that they were first diagnosed with CFS. And then as the disease progressed and symptoms got worse, the diagnosis changed to MS. They also said that they were found to have chlamydia pneumoniae and are now improving on antibiotics. Sorry I don't recall who passed this info to me.

rheumatic MS

Hi, Hoping someone can help me, a Dr did extensive blood work on me and then did not explain much of it..I noticed in the copies he gave me that it is noted I have high myelin sheath deteriotion that occurs in MS..yet this DR was more concerned with the accompanying virus's, Epstein Barr, CMV and HH6..I did a little research and found that HH6 occurs in 1/3 of patients with MS..The Alternative MD who did the blood, when asked if I had MS, said he did not know...anyone with any info? thanks, DEBB To unsubscribe, email: rheumatic-unsubscribeegroups

Link to comment
Share on other sites

Guest guest

Be aware that you also will find high mylin sheath deteriotion that occurs with Lyme disease. you may want to search Goggle (deja.com) diseases, lyme disease. I suspect many people on this bulletin board are actually infected with Borellia bacteria which causes lyme (and then the immune system becomes challenged and we pick up all sorts of other bacteria, parasites, mycoplasms and viruses....also heavy metals that the body can no longer detox). But you find the white plaqueing in both lyme and ms. More and more people are finding they actually have Lyme and not ms (or lyme that is misdiagnosed) . the good thing is that lyme responds fairly well to antibiotics (but it is a very difficult bacteria) kathy

rheumatic MSHi, Hoping someone can help me, a Dr did extensive blood work on me and then did not explain much of it..I noticed in the copies he gave me that it is noted I have high myelin sheath deteriotion that occurs in MS..yet this DR was more concerned with the accompanying virus's, Epstein Barr, CMV and HH6..I did a little research and found that HH6 occurs in 1/3 of patients with MS..The Alternative MD who did the blood, when asked if I had MS, said he did not know...anyone with any info? thanks, DEBB To unsubscribe, email: rheumatic-unsubscribeegroups

Link to comment
Share on other sites

Guest guest

Dear Sherry,

Yes, I did have the dye injected and everything looked extremely normal. I am not sure what I've got really, but I know I get worse with excercise and chemical exposure. Every time I have done any significant excercise, like a game of tennis, or using an excercise machine or going back to work, I've ended up more debiliatated than I was before. It usually takes about 2 months of doing more than I feel I can cope with and I end up in a relapse. The muscles in my back and legs have wasted and it's not like I do a lot now that my children have left home. Fortunately now I have a husband who helps with lots of things and does not expect too much of me.

Wishing you health and peace,

Rosemary.

rheumatic MS

Hi, Hoping someone can help me, a Dr did extensive blood work on me and then did not explain much of it..I noticed in the copies he gave me that it is noted I have high myelin sheath deteriotion that occurs in MS..yet this DR was more concerned with the accompanying virus's, Epstein Barr, CMV and HH6..I did a little research and found that HH6 occurs in 1/3 of patients with MS..The Alternative MD who did the blood, when asked if I had MS, said he did not know...anyone with any info? thanks, DEBB To unsubscribe, email: rheumatic-unsubscribeegroups

Link to comment
Share on other sites

  • 1 year later...

I also use the Zapper. Its inexpensive, painless, noninvasive and if H.

is correct, it could be very helpful. kathy

BTW , have you had trouble with your wrist band connections? Mine

always give me trouble.

rheumatic MS

>

>

> > Hi,

> > I was wondering if somebody could give me some info on AP and MS.

> > A friend of the family just got diagnosed with MS, and I have read

> > that AP has shown some good results with some MS patients. I would

> > really like to try and help her out. Thanks in advance for any info.

> > Take Care,

> > Chelsie

> >

> >

> >

> > To unsubscribe, email: rheumatic-unsubscribeegroups

> >

> >

> >

Link to comment
Share on other sites

Hi Chelsie,

Are you familiar with Dr. Hulda and her " zapper " ? Take a look at her

website at www..net

She believes that infection is at least part of the cause of MS, rheumatoid

arthritis, and many other diseases. And her zapper is used to kill off the

infection with low-voltage electricity (without the use of oral

antibiotics.) Many people think she is crazy, but I use her zapper and have

seen improvement in both my arthritis and juvenile diabetes. It's worth

looking into.

Let me know how it goes.

rheumatic MS

> Hi,

> I was wondering if somebody could give me some info on AP and MS.

> A friend of the family just got diagnosed with MS, and I have read

> that AP has shown some good results with some MS patients. I would

> really like to try and help her out. Thanks in advance for any info.

> Take Care,

> Chelsie

>

>

>

> To unsubscribe, email: rheumatic-unsubscribeegroups

>

>

>

Link to comment
Share on other sites

Hi

Chelsie,

I do have many articles.

I think I will post some here.

ome conciliatory news (at least I think it is) from the MSQR-

Multiple Sclerosis Quarterly Report--Spring 2002.

Antibiotic May be A Potential Therapy for M.S.

A common antibiotic, long used to treat infections in humans, may

have potential as a treatment for M.S., according to a new study

published in the medical literature in December 2001. The drug,

minocycline, is a member of the tetracycline family of antibiotics

and was tested in a condition that mimics M.S. Study results portray

a potential treatment for M.S. that could significantly decrease the

severity of disease attacks or even block the onset of relapses,

hence ameliorating many of the disease's debilitating symptoms.

Minocycline is already used to treat several different infections,

but it is also effective in rheumatoid arthritis-an inflammatory

condition. Due to this anti-inflammatory property, researchers at the

Univ. of Wisc.-Madison gave minocycline to rats with a disease that

closely resembles the inflammatory process of human M.S. Senior

researcher Ian D. Duncan, Ph.D., reports that " animals treated with

minocycline did not develop nerve problems, or had a less severe

case, than did untreated rats.The results also showed that they could

treat the animals successfully either before or after the disease

began. "

The hope is that minocycline may be able to significantly decrease

the severity of attacks in M.S. or even block relapses completely. By

doing so, it could relieve many of the symptoms, from paralysis to

blindness, that plague people with this disease. Studies of

minocycline in humans with M.S. will begin in 2002 at the Univ. of

Calgary, Canada. " It is very important that a well-conducted clinical

trial is carried out to test whether it is safe and effective in

M.S., " says Duncan. He adds that minocycline would have advantages

over drugs presently used because it is less expensive, can be taken

by mouth, and could be used short-term to stop disease progression.

(webMD)

**************************************************************

MULTIPLE SCLEROSIS

Gabe Mirkin, M.D.

Here is an example of how difficult it is for doctors to accept new

thinking on the causes and treatments of diseases. Multiple sclerosis

is characterized by repeated episodes of nerve damage and recovery.

For example, a person may lose vision and regain it, then lose

coordination for one arm and leg, then regain some coordination, and

so forth, each time losing more than is regained. Doctors do not have

an effective treatment because they don't know the cause. The most

likely cause is an infection because 85percent of patients do not

have an affected relative and only one in three identical twins of MS

patients develops MS.

In the last year several researchers have presented evidence that

chlamydia pneumoniae may be the cause (1,2). It has recently been

detected in the cerebrospinal fluid of multiple sclerosis patients,

but not in that of patients with other neurological diseases. There

is also a report of a patient with spinal chlamydia infection and

rapidly progressive multiple sclerosis that was cured by minocycline,

a very safe antibiotic. Because nerve damage caused by multiple

sclerosis can be permanent and minocycline is so safe, doctors should

offer this treatment to multiple sclerosis patients, provided that

they tell them that this treatment must be considered experimental,

because chlamydia has not been proved to cause multiple sclerosis and

minocycline has not been tested to see if it can cure that disease.

Five years ago, researchers at the National Institute of Health

reported that multiple sclerosis may be caused by human herpes

simplex virus six. Four year ago, researchers at the University of

Wisconsin reported the same results. Three years ago, researchers at

the Rockefeller University in New York reported the same results.

However, no studies have been done to treat multiple sclerosis with

drugs that kill human herpes virus-6, Gancyclovir or fornascat,

probably because many researchers are afraid of its toxic side

effects.

1) Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid

is a common phenomenon in a variety of neurological diseases and not

restricted to multiple sclerosis. ls of Neurology, 2001, Vol 49,

Iss 5, pp 585-589. J Gieffers, D Pohl, J Treib, R Dittmann, C

Stephan, K Klotz, F Hanefeld, W Solbach, A Haass, M Maass. Address:

Gieffers J, Med Univ Lubeck, Inst Med Microbiol & Hyg, Ratzeburger

Allee 160, D-23538 Lubeck, GERMANY.

2) An infectious basis for multiple sclerosis - Perspectives on the

role of Chlamydia pneumoniae and other agents. H Moses, S Sriram.

Biodrugs, 2001, Vol 15, Iss 3, pp 199-206.Address: Sriram S,

Vanderbilt Stallworth Rehabil Hosp, Multiple Sclerosis Res Lab &

Clin, 2201 Capers Ave, Room 1222, Nashville,TN 37212 USA

Health Topics from • The Dr. Gabe Mirkin Show and DrMirkin.com• Box

10, Kensington MD 20

____________________________________________________

Posted November 9, 2001 · Issue 114

>

>

>Abstract

>

>When renowned pathologist Luther E. Lindner found " strange

organisms " in

>human blood and tissue, he was intrigued. Now Lindner along with a

>Texas-based company called Pathobiotek say a newly discovered, blood-

based

>bacterium may be the long-sought trigger for multiple sclerosis,

chronic

>fatigue syndrome, and other forms of autoimmune disease.

>

>One of the most confounding diseases of modern times,

><http://www.ninds.nih.gov/health_and_medical/disorders/multiple_scler

osis.h

>tm>multiple sclerosis (MS) is caused by destruction of the fatty

myelin

>sheath that normally insulates neurons and enables signals to pass

from

>one nerve cell to the next. Symptoms, when nerve signals are

subsequently

>slowed or halted, range from mild numbness in the limbs to dramatic

>cognitive decline, paralysis, and loss of sight.

>

>Most experts believe that the destructive process is autoimmune in

nature,

>spurred when the body's immune cells attack the cells of the central

>nervous system. Scientists have, in recent years, identified the

rogue

>immune cells involved in the destruction, even pinpointing the

receptor

>sites that cause these cells to latch onto myelin, prompting the

mayhem to

>begin. But while researchers have mapped the process, they don't

know what

>sets it off. Prime suspects have been viruses, already implicated in

>demyelination of nerves. Yet investigation of more than a dozen

viruses,

>including measles, canine distemper, and herpes (HHV-6) have failed

to

>show cause and effect.

>

>Now a Texas-based company called

<http://www.pathobiotek.com/>Pathobiotek

>Diagnostics says a newly discovered, blood-based bacterium may be a

>trigger for MS,

<http://www.cdc.gov/ncidod/diseases/cfs/index.htm>chronic

>fatigue syndrome (CFS), and other forms of autoimmune disease. It

all

>started a few years back when respected pathologist

><http://hscconcord.tamu.edu/pathology/Luther%20Lindner%

20Research.htm>Luthe

>r E. Lindner joined colleagues and investors to pursue " the strange

>organisms " he'd found in human blood and tissue over the years. As

part of

>that effort, a researcher working under Lindner used a novel culture

>system to see if he could identify the spirochete

><http://www.pasteur.fr/recherche/borrelia/Welcome.html>Borrelia

>burgdorferi in a patient thought to have

><http://www.cdc.gov/ncidod/dvbid/lyme/index.htm>Lyme disease, often

so

>similar to MS and CFS that the conditions may seem

indistinguishable. " Lo

>and behold, " says Lindner, " we saw a few bacteria wiggling around,

but

>they were not spirochetes and, so, clearly not B. burgdorferi or

Lyme. "

>

>Lindner was, to put it mildly, intrigued. " The general dogma in

medicine

>up until very recently, " he explains, " is that the bloodstream in

normal

>people is sterile. It was not supposed to have bacteria floating

around in

>it, but there they were. "

>

>Pursuing the discovery, Lindner studied a group of 66 patients with

CFS,

>MS, and other forms of autoimmune disease, including

><http://www.duq.edu/PT/RA/RA.html>rheumatoid arthritis and

><http://www.lupus.org/>lupus. Focusing on MS patients alone, he made

a

>notable observation: Those with symptoms had the odd bacteria

present in

>high numbers, while those in remission generally did not. To

determine

>whether the bacteria and the symptoms were truly related, he began

>treating symptomatic patients empirically with antibiotics, changing

>medications when symptoms remained. If patients were treated long

enough,

>from two to six months and in some cases more, he says, " about 50

percent

>improved. We observed that symptomatic treatment correlated with

levels of

>bacteria in the blood. "

>

>Despite his ability to improve the outcome for many patients,

however,

>there were roadblocks to overcome. For one thing, a percentage of

patients

>responded to antibiotic treatment by getting drastically sicker than

>they'd been before. It turns out, says Lindner, that antibiotics in

this

>subgroup of patients stimulated bacterial growth, an effect he has

traced

>to a specific pump in the bacterial cell walls. Thus, even though

>treatment was helpful for many patients, it was still a game of

Russian

>roulette. " The results are not predictable. Without tests to

identify

>antibiotic sensitivity levels in each patient, " he says, " we cannot

not

>recommend this treatment at all. "

>

>In addition, the culturing system Lindner used to guide his research

was

>crude. " It relied basically on microscopic observation and

microscopic

>counting, " he says. " You can't be a hundred percent sure of what

you're

>looking at under the microscope. " In order to be sure of his

findings, he

>had to look at the organism at the genetic level, sequencing its

DNA. To

>take Lindner's work to the next level, Pathobiotek has been focusing

on a

>technology platform aimed at characterizing and quantifying the

newly

>found organism through state-of-the-art molecular and

microbiological

>tools. One result has been identification of the organism's DNA by

>polymerase chain reaction (PCR), proving it is truly unique.

Reflecting

>this finding, Pathobiotek has registered " Human Blood Bacterium, " or

HBB,

>as United States Patent 6,255,467, issued in July 2001.

>

>The company has also been hard at work on improving culturing

techniques

>using DNA analysis for confirmation of organism identity. " It has

been a

>long, slow process, " says Lindner, " but the new culturing system is

>several orders of magnitude better than the original. " One result of

>culture advancements has been the finding that the organism is

present, in

>low number, in all or nearly all people. " We can grow them from

everyone, "

>he states. The Lindner team has also learned that the organisms

consist of

>three or four closely related species of Methylobacteria, a class

usually

>found living in the environment. " So far we haven't found a

particular

>species or strain to correlate with whether or not the patient has

>symptoms, " Lindner adds, " though we continue to look. And although

we have

>been looking fairly hard, we have yet to find any mechanism that

would

>explain why certain patients have symptoms while others do not. We

are now

>working on quantitative PCR to see whether we can confirm our

original,

>crude associations in a more precise way. "

>

>The company also hopes to help physicians and other researchers

consider

>this new organism when diagnosing, treating, or studying the

spectrum of

>autoimmune disease that includes CFS and MS. Toward that end, it

intends

>to market several kits enabling researchers to confirm the presence

of the

>microorganism from either serum or culture samples. New techniques

>involving quantitative PCR, as well as monoclonal and polyclonal

>antibodies currently under development will soon allow labs to assay

the

>varying levels of the microorganism in humans.

>

>The company is also trying to understand the mechanism of the cell-

wall

>pump that can respond to antibiotics by making some patients

especially

>ill. " We don't know what the pumps are moving in and out of the

bacteria, "

>says Lindner, " but we've found that some solvents influence their

>behavior, flipping them back and forth. " What's more, he

notes, " certain

>patterns of diet may do the same. " The group has learned, for

instance,

>that niacin tends to turn up the pumps, stimulating growth of the

>bacteria. Other nutrients may do the reverse.

>

>Finally, Pathobiotek is working hard to identify antibiotic

sensitivity

>levels in autoimmune patients, a prerequisite for delivering

therapeutic

>treatment at all. Already, the team has discovered that one

antibiotic,

>clarithromycin, is likely to stimulate bacterial growth in most

patients.

>The goal is providing a sensitivity test that would help customize

>treatment for each and every patient while significantly lowering

the

>risk. One of the most important aspects of Lindner's work could be

the

>finding of bacterial persistence following antibiotic therapy. Many

>experts contend that autoimmune disease, while perhaps triggered by

>infection, continues its assault long after the microbes have been

killed.

>But Lindner's findings suggest that autoimmune illness may be driven

by

>persistent infection - when infection subsides, his research

indicates,

>autoimmune symptoms do, too. " I don't know of any way to get rid of

this

>organism, " Lindner says. " The best we can do is reduce its levels.

We

>don't know why. We have no proof at this point that they are

intracellular

>and, thus, hidden from antibiotics, but their persistence in the

body

>suggests that may be the case. " Another theory, he notes, is that

human

>blood bacteria cross the placenta. If the organisms are present

prior to

>birth, they may not be recognized as foreign by the immune system

and,

>thus, may be especially difficult to clear.

>

>When all is said and done, Lindner concedes, human blood bacteria

may not

>be the long-sought trigger for MS, CFS, and other forms of

autoimmune

>disease. " There is always the possibility that the changes in the

>bacterial level are a secondary effect, " he states. " If so, it would

still

>be a significant marker of disease activity. On the other hand, if

these

>organisms are truly causative, sooner or later we will find a means

to

>control them. "

>

>Due to corporate restructuring, Pathobiotek will soon be changing

its name

>to Adesy, Inc., and will be moving corporate offices to a different

Texas

>location.

>><http://news.bmn.com/hmsbeagle/current/about/contrib3#weintraub>Pame

la

>>Weintraub is a former staff writer at Discover, former editor-in-

chief of

>>Omni Internet, and the author of 15 books on health and science.

>

>

> Wolsborn is Web designer of HMS Beagle

>

>

>Endlinks

>

><http://www.sky.net/~dporter/MSCFSABX.htm>Multiple Sclerosis and

Chronic

>Fatigue Syndrome: A Bacterial Etiology? - an article written by

Luther E.

>Lindner in response to requests for information about his research.

>

><http://journals.bmn.com/search/site?

search_action=resolve & uid=TIM.etd00836

>_0966842x_v0009i08_00002097 & rendertype=abstract>Viruses and

Autoimmune

>Disease: Two Sides of the Same Coin? - examines experimental models

on the

>role of viruses. From Trends in Microbiology, 2001, 9:8:377-381.

Full text

>available from BioMedNet.

>

><http://journals.bmn.com/search/site?

search_action=resolve & uid=JIMM.etd0051

>5_09527915_v0012i06_00000162 & rendertype=abstract>The Role of

Different

>Subsets of T Regulatory Cells in Controlling Autoimmunity - focus on

the

>role of T regulatory cells in prevention of autoimmunity and

maintenance

>of homeostasis. From Current Opinion in Immunology, 2000, 12:6:676-

683.

>Full text available from BioMedNet.

>

><http://journals.bmn.com/search/site?

search_action=resolve & uid=JIMM.etd0051

>5_09527915_v0012i06_00000166 & rendertype=abstract>Antigen-Specific

Therapy

>for Autoimmune Disease - discusses the paradoxical use of self-

antigens as

>tools for autoimmune disease therapy. From Current Opinion in

Immunology,

>2000, 12:6:704-711. Full text available from BioMedNet.

>

><http://journals.bmn.com/search/site?

search_action=resolve & uid=JIMM.etd0051

>5_09527915_v0012i06_00000163 & rendertype=abstract>Animal Models of

>Autoimmunity and Their Relevance to Human Diseases - reviews recent

>advances. From Current Opinion in Immunology, 2000, 12:6:684-690.

Full

>text available from BioMedNet.

>

><http://www.niaid.nih.gov/publications/autoimmune/autoimmune.htm>Unde

rstand

>ing Autoimmune Disease - an online booklet from the National

Institute of

>Allergy and Infectious Diseases, National Institutes of Health.

>

><http://www.immunologylink.com/>Immunology Links - includes

worldwide

>associations, journals, job opportunities, and technical information

for

>immunologists.

>

><http://www.nationalmssociety.org/>National Multiple Sclerosis

Society - a

>gateway to information on MS.

>

>Related HMS Beagle articles:

> * <http://news.bmn.com/hmsbeagle/108/notes/meeting>International

> Congress of Immunology - a report from the conference held July 23-

27,

> 2001 in Stockholm.

> * <http://news.bmn.com/hmsbeagle/103/notes/meeting>American

Society

> for Microbiology - highlights from the conference include

> <http://news.bmn.com/hmsbeagle/103/notes/meeting1>Evidence for

Molecular

> Mimicry in Multiple Sclerosis.

>

>© Elsevier Science Limited 2000

>

__________________________________________

AUTOIMMUNE NEUROLOGICAL AND RHEUMATIC DISEASES: ROLE OF CHRONIC

INFECTIONS IN MORBIDITY AND PROGRESSION

Prof. Garth L. Nicolson and L. Nicolson

The Institute for Molecular Medicine (Website www.immed.org)

15162 Triton Lane, Huntington Beach, CA 92649-1401

Autoimmune neurological and rheumatic diseases unfortunately do not

have known causes, and in most cases, effective treatments. Although

there has been tremendous progress in the last few years on these

diseases, they still remain among the most difficult diseases to

manage. The Institute for Molecular Medicine has been working with

its affiliated institutions to develop new diagnostic and therapeutic

approaches to treating autoimmune diseases.

MICROORGANISMS CAUSE MORBIDITY IN MANY CHRONIC ILLNESS PATIENTS

Although the causes of autoimmune neurological diseases are for the

most part unknown, the complex signs and symptoms that evolve in most

patients may be due, in part, to systemic chronic infections

(bacteria, viruses, fungi) in patients with an appropriate genetic

background. Such infections can follow acute or chronic chemical or

other insults (heavy metal, viral, environmental, trauma, etc.) that

have the potential to suppress the immune system [1]. Thus these

illnesses probably evolve over time as a multistep process that may

require multiple toxic exposures, including infections that can be

causative for the illness in some patients, cofactors for the illness

(not causative but important to morbidity) in others or opportunistic

in immune-compromised patients. Chronic infections that are usually

held in check by our immune systems can take hold if they can avoid

immune surveillance and penetrate and hide in various tissues and

organs, including cells of the Central Nervous System (CNS) and

Peripheral Nervous System (PNS). When such infections occur, they can

cause complex signs and symptoms, including immune dysfunction.

Changes in environmental responses as well as increased titers to

various endogenous viruses that are commonly found to be expressed in

these patients as well as bacterial (Mycoplasma, Chlamydia, Borrelia,

Brucella, etc.) infections have now been commonly seen in autoimmune

neurological similar to other autoimmune disease patients, such as

Rheumatoid Arthritis [2, 3].

It is proposed that autoimmune signs and symptoms are caused when

intracellular pathogens, such as mycoplasmas and other bacteria,

escape from cellular compartments. Microorganisms like mycoplasmas

can incorporate into their own structures pieces of host cell

membranes that contain important host membrane antigens that can

trigger autoimmune responses, and they can also mimic host cell

antigen structures [2, 3]. Thus patients with such infections may

respond immunologically to microorganism antigens as well as their

own membrane antigens, producing unusual autoimmune signs and

symptoms.

MULTIPLE SCLEROSIS (MS)

Multiple Sclerosis (MS) is a disease associated with demyelation with

relative preservation of nerve cells. Nerve cell loss does occur

(~20%) in typical lesions in the spinal cord. MS is an inflammatory

disease in which there is damage to the blood brain barrier, focal

edema and swelling and release of plasma proteins into the CNS and

inflammatory responses. The disease runs an intermittent or cyclic

course, and the initial diagnosis is usually made after several

attacks of disability associated with damage to the CNS. Although

there is a poor correlation between a MS patient's disability and the

pathology found in the brain after death, small lesions imaged in the

brainstem and spinal cord are usually associated with clinical signs

and symptoms [4].

In the case of MS, there is evidence for an association of the

disease with chronic bacterial and viral infections. Challoner et al.

[5] found MS plaque-associated expression of the herpes virus HHV-6B

in >70% of MS cases. More recently Friedman et al. [6] used PCR and

serology to follow HHV-6 infections in MS (plaques) and non-MS brain

sections and found that ~40% of MS patients expressed HHV-6, whereas

HHV-6 protein was expressed in only 13% of non-MS brain sections and

0% of normal controls. Also, antibodies to HHV-6 were found in 80% of

MS patients but only 16% of non-MS patients. Evidence for a systemic

infection have been noted by Kim et al. [7] and Akhyani et al. [8]

who found HHV-6 in the peripheral leukocytes of MS patients but not

in control subjects. Extending these observations Knox et al. [9]

found that 73% of patients with MS had HHV-6 infections in tissues

sections showing active demyelination, whereas only 13% of sections

free of active disease were positive. Blood samples from these

patients showed that 54% were positive for HHV-6 in peripheral

leukocytes compared to 0/61 controls.

In addition to HHV-6, bacterial infections have been found in MS

patients. There are strong analogies between neuroborreliosis

(Borrelia bergdorferi) found in Lyme Disease patients and MS.

Chmielewska-Badora et al. [10] found that 38.5% of MS patients showed

evidence of Borrelia antigens in their blood, whereas other

neurological patients carried these antigens in blood at a lower

prevalence (19%). Chlamydia pneumoniae has also been found in a

subgroup of MS patients [11]. By examining cerebral spinal fluid

(CSF) these authors found that 10% of MS patients and 18% of patients

with probable MS had Chlamydia infections but none of 56 control

patients with other neurological disease were positive [11]. Other

authors, however, could not confirm this finding [12]. We have found

a high incidence of mycoplasmal infections in MS patients, mostly as

coinfections with other bacteria and viruses. Greenlee and Rose [4]

have discussed the possible association of various bacterial

infections caused by Rickettsia, Mycoplasma, Borrelia, Chlamydia and

possibly other bacteria and viral infections caused by HHV-6 in

various neurological diseases, including MS.

Recently we established a new treatment protocol for MS based on the

detection of chronic bacterial and viral infections in MS patients.

Hyperbaric oxygen therapy (HBOT) has been shown to be of benefit in

many disorders, and it has been documented to be beneficial in MS

[13]. Thus there is an existing rationale for using HBOT to treat MS

patients, especially those MS patients with evidence of chronic

infections. The chronic infections that have been found in some MS

patients are borderline anaerobic infections and should respond to

varying degrees to HBOT. The current treatment for chronic

infections, such as those caused by bacterial infections, is long-

term antibiotics plus nutritional support. The antimicrobial effects

of antibiotics are often thought to be potentiated by the use of

HBOT. In one part of the study we will evaluate the effects of using

HBOT to treat MS with evidence of a chronic infection using signs and

symptoms, sequential imaging, and determination of infections and

immune parameters to monitor effect of therapy. It is anticipated

that 50 subjects will be enrolled in this study.

I have 2 more as well but they are longer

Love

Marge

> Hi,

> I was wondering if somebody could give me some info on AP and MS.

> A friend of the family just got diagnosed with MS, and I have read

> that AP has shown some good results with some MS patients. I would

> really like to try and help her out. Thanks in advance for any info.

> Take Care,

> Chelsie

Link to comment
Share on other sites

Hi Chelsie

KB from the RBF...I read a very interesting article back on the RBF

BB. I believe a person named posted it around the 19th of

september???? It's about mercury amalgans and the disease process.

Search for Mercury. This article is a real eye opener! I gave it to

a friend of mine who was resently rx'd with ALS. I've also given a

copy to my allergist, she was floored, and called her friend who has

severe kidney problems. It seems that mercury exposer (silver

fillings) causes all kinds of problems/diseases.

Chelsie, read this article, read it a couple of times, 'cause

different things will bounce out at you. For you, you may be

intrested to read that you shouldn't have dental work done while your

pregnant...the mercury vapors can cause problems for the fetus.

Let me know if you have problems finding the article, I'll help you.

KB

Link to comment
Share on other sites

  • 1 month later...

Hi Jan...your rice stuffing sounds great. My mom used to stuff chickens

with a special wild rice & herb recipe when we were little...still makes

my mouth water.

I'm giving the lady the benefit of her sincerity...I'm sure she was

reading from a script, but she was very sweet. It just put me off...but

I won't stop helpng where I can.

I hope you & yours have a WONDERFUL holiday.

Much Love...

Tess

Link to comment
Share on other sites

  • 2 years later...
Guest guest

I am sorry you missed the show. He had several people on it who had MS, a young mother who was diagnosed at age 16. She is now in her 20's, married to a surgeon, who wrote the book, The Gold Coast Cure. It is coming out in June. He has done a lot of research on diet, - didn't get his name, though. Also, a country western singer, who will be going on tour with Montel to raise money for research for MS. Go to Montel's website for more information. A doctor also talked about children as young as three being diagnosed.

Montel uses alternative and complimentary medicine - Chinese Herbs - says that is what is keeping him going.

Joan, PACol. Potter's Cairn Rescue May you have a song in your heart, a smile on your lips and nothing but joy in your fingers.

Re: MS

I missed it. I was picking the kids up from school and we had an appointment after that. What did he have to say? I tried to send him an email many years ago about the German treatment, but I don't know if he ever received it. I never had a reply from him......Joan Cowdrick <scrappygal@...> wrote:

Wednesday, June 1, 2005

Montel in talking about MS today at 2:00 P.M.

Joan, PACol. Potter's Cairn Rescue May you have a song in your heart, a smile on your lips and nothing but joy in your fingers.

Link to comment
Share on other sites

  • 2 weeks later...
Guest guest

<janel@p...> wrote:

> Re: bacterial loads, I suspect the MS patients can attribute the

majority of their symptoms to the immune response attacking the

myelin sheath (not necessary for them to have a high bacterial load

to have devastating symptoms) whereas the symptoms of many people

with TBDs might not be due to their immune syst going beserk

and " auto-immuning " , but just to " appropriate inflammation (?) " when

confronted to a very high bacterial load. Just thinking outloud, pure

speculation.

The demyelination may not require any autoimmunity at all, and no

autoimmune epitope has ever been identified. The myelin sheaths come

from extensions of oligodendrocytes. When oligodendrocytes die they,

like most any cell, expose phosphatidyl(sp?) serine on their

membranes, and fix complement. The myelin sheaths are left, and are

then phagocytosed.

Barnett and Prineas recently observed that all the oligodendrocytes

in the lesions all die rapidly, prior to the arrival of any

leucocytes, in many lesions (apparantly not all). Great, but the big

question is why do they die.

Well, I would wildly speculate that other glial cells (the non-

neurons of the brain) are charged with killing them under some

conditions, perhaps as a " scorched earth " strategy for containing

pathogens that like oligodendrocytes. Like when ancient towns under

attack burned their fields before withdrawing into the citidel. I

have a couple papers showing that certain toxic situations kill

oligos when cultured with other glia, but not oligos in pure culture.

Im totally just blabbering here.

Now, thats demyelination. Theres also a great capacity for re-

myelination, which is why MS can remit, and the breakdown of this

capacity is seen in progressive MS. That could be like a whole nother

phenomenon. Autoimmunity? Certainly a possibility.

Link to comment
Share on other sites

Guest guest

,

I used "autoimmunity" with quotes as that's the "explanation" that is commonly given for MS, but I have no idea whether there even is such a thing as autoimmunity.

Your explanation suits me fine (but again, who knows?!)

I was only commenting on the bacterial load aspect, saying that even severe and spectacular symptoms might not always mean a higher bacterial loads (MS or no MS) yet die-off when using abx might very well depend on how high the bacterial load is (pbbly among other things of course)

Nelly

Link to comment
Share on other sites

Guest guest

Oh yeah, I wasnt objecting to what you were saying, I just like

studying MS, probably cause I dont have it. I love to blather about MS

at the slightest provocation, beware mentioning it! I wish I could get

into some heavy papers I have on the subject but I'm too busy.

Did you read the whole thread that was linked here the other day, the

one Wheldons on? I didnt read it all, but one person described a

pretty severe rx to a cycline that could well have been herx.

Interestingly, Mattman has some data on the MS spirochete having

different cyst morphology than the CFS/lyme Bb.

> ,

>

> I used " autoimmunity " with quotes as that's the " explanation " that is

commonly given for MS, but I have no idea whether there even is such a

thing as autoimmunity.

>

> Your explanation suits me fine (but again, who knows?!)

>

> I was only commenting on the bacterial load aspect, saying that even

severe and spectacular symptoms might not always mean a higher

bacterial loads (MS or no MS) yet die-off when using abx might very

well depend on how high the bacterial load is (pbbly among other things

of course)

>

> Nelly

Link to comment
Share on other sites

  • 4 months later...

> I was even more interested in their reference (see abstract below)

> purporting to show AI in MS in the form of directly-observed

> anti-myelin Ab bound to disintegrating myelin membrane.

THis abstract is relevant to whether or not these myelin-binding Ab

are pathogenic or not. I have the paper, a very long one with 250

refs.

It is also very well known that apoptotic cells expose

phosphatidylserine, which is usually only found on the inner leaflet

of the plasma membrane, and that this can be bound by macrophages as

I recall.

========================================================

Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):217-43.

Immunoregulation of cellular lifespan: physiologic autoantibodies and

their peptide antigens.

Kay MM, Goodman J.

Department of Neurology, University of Geneva Hospital, Micheli du

Crest 24, CH 1211, Geneva, Switzerland. margueritekay@...

Physiologic autoantibodies are part of our normal immune repertoire

where they function to maintain homeostasis by performing physiologic

functions. The role of physiologic autoantibodies in removing

senescent and damaged cells is probably the best example of a

physiologic autoantibody, complete with well established function.

IgG autoantibodies bind to altered band 3 anion exchanger protein on

senescent cells and trigger their removal by macrophages. Band 3

isoforms are found in all cells, tissues, and membranes, and in all

species examined. In this paper, we discuss the innate immune

response to band 3 membrane proteins and their regulation of cellular

lifespan. The role of physiologic autoantibodies and their peptide

antigens in health and disease, apoptosis, and their therapeutic

potential is discussed focusing on the examples of senescence and

malaria.

Publication Types:

Review

Review, Tutorial

PMID: 12887104 [PubMed - indexed for MEDLINE]

Link to comment
Share on other sites

  • 2 months later...

Personally, if I had MS the first thing I would try - based on

excellent anecdotal treatment success, and assuming I read in depth

about any/all risks and accepted them - would be a multi-antibacterial

regime probably including a nitroimidazole (metronidazole or

tinidazole). I'm told some such regimes are compatable with some of

the more canonical MS treatments.

Many MS patients using multiple abx therapy, and mulling over the

evidence for bacterial infection in MS, may be found at

thisisms.com antibiotics forum

cpnhelp.org

lymenet.org

Most of these communities focus on borrelia or Chlamydia pneumoniae,

which are certainly present in the brain in some MS cases... tho in my

opinion you cant really exclude that some other bacterium (or other

microbe or something else completely) could be a more fundamental

pathogen in the disease at least in some cases. Hopefully one day

we'll find out. For now, we already know enough to fight the disease

about as best we can, IMO.

>

> I've a friend with MS who hasn't done any alternative stuff.

> Any recommendations? She's 47 and diagnosed a few years ago and it's

> progressing so that in the last 6 months her hands are very shakey

and she

> appears more stiff, etc.

>

> I think it was Rich who in the last week posted with a link to an

article

> that was for many things--cfs, ms, etc. I think it was about the

connection

> of cfs to autism. when i went to the link, it also discussed ms. Please

> resend if this sounds familiar and you can find it.

>

> thank you.

>

> Ann

>

Link to comment
Share on other sites

  • 3 weeks later...

Betty

MS is a label not a description of what her problem is. If she hasn't done os I

would advise her to get herself to a lyme doctor and rule out lyme and the

various co-infections. Also look into metal issues particularly if she has

amalgams.

I have been disabled with lyme,babesia and bartonella for 11 years. By treating

them and detoxing metals my neurological functioning has improved.

There are some in the lyme " community " that actually have MS. She may have it or

may not. There are more options available to treat it than MS has.Please contact

me privately if you desire more info.

Phil

MS

My oldest daughter has been diagnosed with Multiple Sclerosis. She had an

appointment with her OB today, and he sent her straight over to another

doctor. Because she is pregnant, they can't do an MRI and spinal tap until

6 weeks after the baby is born. But he told her that he is pretty sure that

is what she has...she has every symptom.

Anyone here that has it? She is 27 years old, and due with her second baby

in March. Any advice?

Betty

Link to comment
Share on other sites

There are strong links between MS (and other auto-immune diseases) and diary

consumption, and yes raw milk is equally culprit, or more culprit in some

studies. There are also known links to high meat consumption. I personally

(through reading research) believe that it’s linkd to milk-protein (casein)

reactions (like allergic reactions, which are not always apparent to

people), at least in part, as this reaction is the kind that’s linked to

other auto-immune diseases, including diabetes, and chronic

inflammatory-related heart-disease. I’m not sure how the high-meat

consumption would fit in though, but imagnine it’d be similar to whatever

pathways cause the much higher cancer incidence in high-meat (and dairy)

consumers. Gluten intolerance may be anotoher link to MS. One abstract below

follows tries to find a saturated fatty-acid link. If she’s overweight,

weight-loss with vegatable-focussed diet might help, as obesity is another

link (although not obese vegans). There’s not much link to cheese

consumption. Cheese is pre-digested by fungi and thus it’s not only less

allergenic, but other factors in it are altered as well. PLEASE TELL ME IF

THE BELOW ABSTRACTS DO NOT SHOW-UP. linda

HYPERLINK

" javascript:AL_get(this,%20'jour',%20'Neuroepidemiology.'); " Neuroepidemiolog

y. 1992;11(4-6):304-12.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Display & dopt=pu

bmed_pubmed & from_uid=1291895 " Related Articles, HYPERLINK

" javascript:PopUpMenu2_Set(Menu1291895); " Links

HYPERLINK

" http://ucelinks.cdlib.org:8888/sfx_local?sid=Entrez:PubMed & id=pmid:1291895 "

Click here to read

Correlation between milk and dairy product consumption and multiple

sclerosis prevalence: a worldwide study.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Malosse+D%22%5BAuthor%5D " Malosse D, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Perron+H%22%5BAuthor%5D " Perron H, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Sasco+A%22%5BAuthor%5D " Sasco A, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Seigneurin+JM%22%5BAuthor%5D " Seigneurin JM.

Laboratoire de Virologie, Faculte de Medecine, CHRU, Grenoble, France.

Multiple sclerosis (MS) epidemiology suggests that different factors are

involved in the clinical expression of the disease. Alimentary cofactors

have already been considered, but mainly theoretically. We have studied the

relationship between MS prevalence and dairy product consumption in 27

countries and 29 populations all over the world, with Spearman's correlation

test. A good correlation between liquid cow milk and MS prevalence (rho =

0.836) was found; this correlation was highly significant (p < 0.001). A low

but still significant correlation was obtained with cream or butter

consumption (rho = 0.619 and rho = 0.504, respectively). No correlation was

found for cheese. These results suggest that liquid cow milk could contain

factor(s) - no longer present in the processed milk - influencing the

clinical appearance of MS. The possible role of some dairy by-products is

discussed in the light of a multifactorial etiology of MS.

HYPERLINK

" javascript:AL_get(this,%20'jour',%20'Neuroepidemiology.'); " Neuroepidemiolog

y. 1993;12(1):15-27.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Display & dopt=pu

bmed_pubmed & from_uid=8327019 " Related Articles, HYPERLINK

" javascript:PopUpMenu2_Set(Menu8327019); " Links

HYPERLINK

" http://ucelinks.cdlib.org:8888/sfx_local?sid=Entrez:PubMed & id=pmid:8327019 "

Click here to read

Correlation analysis between bovine populations, other farm animals, house

pets, and multiple sclerosis prevalence.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Malosse+D%22%5BAuthor%5D " Malosse D, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Perron+H%22%5BAuthor%5D " Perron H.

Army Medical Research Center, La Tronche, France.

In a previous study we analyzed the possible relationship between dairy

product consumption and multiple sclerosis (MS) worldwide. We showed that a

good correlation (Spearman rank p = 0.836), statistically strongly

significant (p < 0.0001), existed between liquid cow milk consumption and MS

prevalence. The interpretation of this strong correlation between MS and

milk consumption is still unclear: fresh milk could be considered as a

cofactor, but it could also reflect a much stronger association with MS of

another unstudied factor, well correlated with milk consumption (yet, this

is not the case for latitude). Obviously, the bovine population in each

country and, particularly milk cows, has to be considered. In the present

study, we analyze the correlations existing between the figures of national

cow milk production and MS prevalence in 20 countries. We also analyze the

correlations with the whole bovine, ovine, caprine, porcine, horse, poultry,

cat and dog populations. Here again we find significant correlations between

(i) cow milk production per inhabitant, (ii) national bovine density per

inhabitant, and (iii) local bovine geographic density, and MS prevalence.

However, these correlations are relatively weaker than that found with fresh

liquid milk consumption in our previous study. No correlation is found with

other farm animals or with pets in the same countries. The epidemiological

significance of these results, suggesting a preponderant role of fresh cow

milk, is discussed.

JUST TO SHOW THAT THE LINK’S BEEN KNOW FOR A LONG TIME:

HYPERLINK " javascript:AL_get(this,%20'jour',%20'N%20Z%20Med%20J.'); " N Z Med

J. 1976 Jun 23;83(566):427-30.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Display & dopt=pu

bmed_pubmed & from_uid=1067488 " Related Articles, HYPERLINK

" javascript:PopUpMenu2_Set(Menu1067488); " Links

HYPERLINK

" http://ucelinks.cdlib.org:8888/sfx_local?sid=Entrez:PubMed & id=pmid:1067488 "

Click here to read

The distribution of multiple sclerosis in relation to the dairy industry and

milk consumption.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Butcher+J%22%5BAuthor%5D " Butcher J.

This report emphasises the striking correlation between the world

distribution of dairy production and consumption and the incidence of

multiple sclerosis. The irregular distribution of multiple sclerosis has

been extensively investigated and many comparative studies of specific

variables undertaken. It seems likely that there could be a combination of

predisposing or precipitating factors involved in its aetiology, and that

some environmental phenomenon plays a part. This report suggests that milk

consumption may be a common aetiological factor.

HYPERLINK " javascript:AL_get(this,%20'jour',%20'J%20Clin%20Epidemiol.'); " J

Clin Epidemiol. 1994 Jan;47(1):43-8.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Display & dopt=pu

bmed_pubmed & from_uid=8283194 " Related Articles, HYPERLINK

" javascript:PopUpMenu2_Set(Menu8283194); " Links

HYPERLINK

" http://ucelinks.cdlib.org:8888/sfx_local?sid=Entrez:PubMed & id=pmid:8283194 "

Click here to read

The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic

features: a factor-analytic study.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Lauer+K%22%5BAuthor%5D " Lauer K.

Department of Neurology, Academic Teaching Hospital, Darmstadt, Germany.

The multiple sclerosis (MS) case-control ratio by state originating from the

U.S. veteran series from World War II (Kurtzke Neurology 1979; 29:

1228-1235) was geographically compared with 46 sociogeographic variables

from the period 1935-1958. Latitude was, by far, the variable most closely

associated with MS in univariate testing. Multivariate analysis by factor

analysis revealed that the MS rate was associated with 2 independent

settings ( " factors " ). The first one was defined mainly socioeconomically and

was characterized by indicators of higher affluence; better nutrition with a

higher meat consumption in particular, and a higher sanitary level were the

prominent features. The second MS-related bundle comprised characteristics

of a colder climate along with further dietary variables (i.e. a diet low in

fish and high in dairy products). The findings suggest a possible

interaction of both socioeconomic and geoclimatic features in the etiology

of MS; sanitation, diet and climate being of particular interest.

HYPERLINK

" javascript:AL_get(this,%20'jour',%20'Minerva%20Gastroenterol%20Dietol.'); " M

inerva Gastroenterol Dietol. 2004 Dec;50(4):317-23.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Display & dopt=pu

bmed_pubmed & from_uid=15788987 " Related Articles, HYPERLINK

" javascript:PopUpMenu2_Set(Menu15788987); " Links

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3310 & uid=15788987

& db=pubmed & url=http://www.minervamedica.it/index2.t?show=R08Y2004N04A0317 "

\nClick here to read HYPERLINK

" http://ucelinks.cdlib.org:8888/sfx_local?sid=Entrez:PubMed & id=pmid:15788987

" Click here to read

[The efficacy of dietetic intervention in multiple sclerosis]

[Article in Italian]

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Agnello+E%22%5BAuthor%5D " Agnello E, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Palmo+A%22%5BAuthor%5D " Palmo A.

S. C. Dietetica e Nutrizione Clinica, S. O. San Giovanni Battista, Torino.

elenagnello@...

The involvement of nutritional factors in the etiopathogenesis of multiple

sclerosis is currently being investigated. Notwithstanding the huge amount

of data present in the literature, the possible etiological or protective

role of nutrients with regard to the disease remain debatable. The

epidemiological data suggest an association between multiple sclerosis and

nutrition; the populations that take in a higher quantity of foods of animal

origin (meat p<0.0001 and dairy products p<0.01) seem to be the most

affected. A role of saturated fatty acids in the etiopathogenesis of

myelinic damage has been hypothesised. Case control studies have identified

certain foods that act as risk factors and others as protection in the onset

of the disease. Some case control studies point to a time-cause relationship

between the intake of total calories (O.R. 2.03) and saturated fats (O.R.

1.88) and the incidence of multiple sclerosis; other prospective studies

failed to confirm this hypothesis, negating the protective effect of a diet

rich in anti-oxidant vitamins and polyunsaturated fatty acids. Intervention

studies are discordant with respect to the effects of polyunsaturated fatty

acid supplements on the course of the disease. In patients with a

progressive chronic form of the disease, polyunsaturated fatty acids did not

demonstrate any effect on the progression of the invalidating lesions.

Interventions on patients suffering from an acute and remittent form have

pointed to the significant effect of treatment with polyunsaturated fatty

acids in slowing down the progression of lesions only in cases with a slight

initial degree of disability or no disability (p=0.001) at all. They do,

however, seem to confirm the hypothesis of an association between the

gravity of the disease and consumption of saturated fats (p<0.05) and show

an improvement trend in patients treated with polyunsaturated fatty acids,

although the data are not statistically significant.

HERE THEY’RE GETTING CLOSER TO THE MILK PROTEIN-INTOLERANCE REACTION LINK:

HYPERLINK " javascript:AL_get(this,%20'jour',%20'J%20Immunol.'); " J Immunol.

2001 Apr 1;166(7):4751-6.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Display & dopt=pu

bmed_pubmed & from_uid=11254737 " Related Articles, HYPERLINK

" javascript:PopUpMenu2_Set(Menu11254737); " Links

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051 & uid=11254737

& db=pubmed & url=http://www.jimmunol.org/cgi/pmidlookup?view=long & pmid=1125473

7 " \nClick here to read HYPERLINK

" http://ucelinks.cdlib.org:8888/sfx_local?sid=Entrez:PubMed & id=pmid:11254737

" Click here to read

T cells of multiple sclerosis patients target a common environmental peptide

that causes encephalitis in mice.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Winer+S%22%5BAuthor%5D " Winer S, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Astsaturov+I%22%5BAuthor%5D " Astsaturov I, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Cheung+RK%22%5BAuthor%5D " Cheung RK, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Schrade+K%22%5BAuthor%5D " Schrade K, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Gunaratnam+L%22%5BAuthor%5D " Gunaratnam L, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Wood+DD%22%5BAuthor%5D " Wood DD, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Moscarello+MA%22%5BAuthor%5D " Moscarello MA, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22O%27Connor+P%22%5BAuthor%5D " O'Connor P, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22McKerlie+C%22%5BAuthor%5D " McKerlie C, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Becker+DJ%22%5BAuthor%5D " Becker DJ, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Dosch+HM%22%5BAuthor%5D " Dosch HM.

The Hospital For Sick Children, Research Institute, Toronto, Ontario,

Canada.

Multiple sclerosis (MS) is a chronic autoimmune disease triggered by unknown

environmental factors in genetically susceptible hosts. MS risk was linked

to high rates of cow milk protein (CMP) consumption, reminiscent of a

similar association in autoimmune diabetes. A recent rodent study showed

that immune responses to the CMP, butyrophilin, can lead to encephalitis

through antigenic mimicry with myelin oligodendrocyte glycoprotein. In this

study, we show abnormal T cell immunity to several other CMPs in MS patients

comparable to that in diabetics. Limited epitope mapping with the milk

protein BSA identified one specific epitope, BSA(193), which was targeted by

most MS but not diabetes patients. BSA(193) was encephalitogenic in SJL/J

mice subjected to a standard protocol for the induction of experimental

autoimmune encephalitis. These data extend the possible, immunological basis

for the association of MS risk, CMP, and CNS autoimmunity. To pinpoint the

same peptide, BSA(193), in encephalitis-prone humans and rodents may imply a

common endogenous ligand, targeted through antigenic mimicry.

THE FULL-TEXT OF THIS PAPER LOOKS AT MS AS WELL... casein in milk protein:

HYPERLINK " javascript:AL_get(this,%20'jour',%20'N%20Z%20Med%20J.'); " N Z Med

J. 2003 Jan 24;116(1168):U295.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Display & dopt=pu

bmed_pubmed & from_uid=12601419 " Related Articles, HYPERLINK

" javascript:PopUpMenu2_Set(Menu12601419); " Links

Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Laugesen+M%22%5BAuthor%5D " Laugesen M, HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22Elliott+R%22%5BAuthor%5D " Elliott R.

Health New Zealand, Auckland, New Zealand. laugesen@...

AIM: To test the correlation of per capita A1 beta-casein (A1/capita) and

milk protein with: 1) ischaemic heart disease (IHD) mortality; 2) Type 1

(insulin-dependent) diabetes mellitus (DM-1) incidence. METHODS: A1/capita

was estimated as the product of per capita cow milk and cream supply and its

A1 beta-casein content (A1/beta) (calculated from herd tests and breed

distribution, or from tests of commercial milk), then tested for correlation

with: 1) IHD five years later in 1980, 1985, 1990 and 1995, in 20 countries

which spent at least US $1000 (purchasing power parities) per capita in 1995

on healthcare; 2) DM-1 at age 0-14 years in 1990-4 (51 were surveyed by WHO

DiaMond Project; 19 had A1 data). For comparison, we also correlated 77

food, and 110 nutritive supply FAO (Food and Agriculture Organization)-based

measures, against IHD and DM-1. RESULTS: For IHD, cow milk proteins

(A1/capita, r = 0.76, p <0.001; A1/capita including cheese, r = 0.66; milk

protein r = 0.60, p = 0.005) had stronger positive correlations with IHD

five years later, than fat supply variables, such as the atherogenic index

(r = 0.50), and myristic, the 14-carbon saturated fat (r = 0.48, p <0.05).

The Hegsted scores for estimating serum cholesterol (r = 0.42); saturated

fat (r = 0.37); and total dairy fat (r = 0.31) were not significant for IHD

in 1995. Across the 20 countries, a 1% change in A1/capita in 1990 was

associated with a 0.57% change in IHD in 1995. A1/capita correlations were

stronger for male than female mortality. On multiple regression of A1/capita

and other food supply variables in 1990, only A1/capita was significantly

correlated with IHD in 1995. DM-1 was correlated with supply of: A1/capita

in milk and cream (r = 0.92, p <0.00001); milk and cream protein excluding

cheese (r = 0.68, p <0.0001); and with A1/beta in milk and cream (r = 0.47,

p <0.05). Correlations were not significant for A2, B or C variants of milk

beta-casein. DM-1 incidence at 0-4, 5-9 and 10-14 years was equally

correlated (r = 0.80, 0.81, 0.81 respectively) with milk protein supply. A

1% change in A1/capita was associated with a 1.3% change in DM-1 in the same

direction. CONCLUSIONS: Cow A1 beta-casein per capita supply in milk and

cream (A1/capita) was significantly and positively correlated with IHD in 20

affluent countries five years later over a 20-year period--providing an

alternative hypothesis to explain the high IHD mortality rates in northern

compared to southern Europe. For DM-1, this study confirms Elliott's 1999

correlation on 10 countries for A1/capita,1 but not for B

beta-casein/capita. Surveys of A1 beta-casein consumption in two-year-old

Nordic children, and some casein animal feeding experiments, confirm the

A1/capita and milk protein/capita correlations. They raise the possibility

that intensive dairy cattle breeding may have emphasised a genetic variant

in milk with adverse effects in humans. Further animal research and clinical

trials would be needed to compare disease risks of A1-free versus 'ordinary'

milk.

HYPERLINK " javascript:AL_get(this,%20'jour',%20'Med%20Hypotheses.'); " Med

Hypotheses. 2001 Aug;57(2):258-75.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Display & dopt=pu

bmed_pubmed & from_uid=11461185 " Related Articles, HYPERLINK

" javascript:PopUpMenu2_Set(Menu11461185); " Links

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048 & uid=11461185

& db=pubmed & url=http://linkinghub.elsevier.com/retrieve/pii/S0306987700913185

" \nClick here to read HYPERLINK

" http://ucelinks.cdlib.org:8888/sfx_local?sid=Entrez:PubMed & id=pmid:11461185

" Click here to read

Upregulation of lymphocyte apoptosis as a strategy for preventing and

treating autoimmune disorders: a role for whole-food vegan diets, fish oil

and dopamine agonists.

HYPERLINK

" http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Search & itool=pu

bmed_Abstract & term=%22McCarty+MF%22%5BAuthor%5D " McCarty MF.

Pantox Laboratories, 4622 Santa Fe St, San Diego, CA 92109, USA.

Induced apoptosis of autoreactive T-lymphocyte precursors in the thymus is

crucial for the prevention of autoimmune disorders. IGF-I and prolactin,

which are lymphocyte growth factors, may have the potential to suppress

apoptosis in thymocytes and thus encourage autoimmunity; conversely, dietary

fish oil rich in omega-3 fats appears to upregulate apoptosis in

lymphocytes. Since whole-food vegan diets may downregulate systemic IGF-I

activity, it is proposed that such a diet, in conjunction with fish oil

supplementation and treatment with dopamine agonists capable of suppressing

prolactin secretion, may have utility for treating and preventing autoimmune

disorders. This prediction is consistent with the extreme rarity of

autoimmune disorders among sub-Saharan black Africans as long as they

followed their traditional quasi-vegan lifestyles, and with recent ecologic

studies correlating risks for IDDM ( THAT’S DIABETES) and for multiple

sclerosis mortality with animal product and/or saturated fat consumption.

Moreover, there is evidence that vegan or quasi-vegan diets are useful in

the management of rheumatoid arthritis, multiple sclerosis, and possibly

SLE. The dopamine agonist bromocryptine exerts anti-inflammatory effects in

rodent models of autoimmunity, and there is preliminary evidence that this

drug may be clinically useful in several human autoimmune diseases; better

tolerated D2-specific agonists such as cabergoline may prove to be more

practical for use in therapy. The moderate clinical utility of supplemental

fish oil in rheumatoid arthritis and certain other autoimmune disorders is

documented. It is not unlikely that extra-thymic anti-inflammatory effects

contribute importantly to the clinical utility of vegan diets,

bromocryptine, and fish oil in autoimmunity. The favorable impact of low

latitude or high altitude on autoimmune risk may be mediated by superior

vitamin D status, which is associated with decreased secretion of

parathyroid hormone; there are theoretical grounds for suspecting that

parathyroid hormone may inhibit apoptosis in thymocytes. Androgens appear to

up-regulate thymocyte apoptosis, may be largely responsible for the relative

protection from autoimmunity enjoyed by men, and merit further evaluation

for the management of autoimmunity in women. It will probably prove more

practical to prevent autoimmune disorders than to reverse them once

established; a whole-food vegan diet, coupled with fish oil and vitamin D

supplementation, may represent a practical strategy for achieving this

prevention, while concurrently lowering risk for many other life-threatening

'Western' diseases. Copyright 2001 Harcourt Publishers Ltd.

_____

From:

[mailto: ] On Behalf Of Betty Pearson

Sent: Tuesday, February 07, 2006 11:17 PM

Subject: MS

My oldest daughter has been diagnosed with Multiple Sclerosis. She had an

appointment with her OB today, and he sent her straight over to another

doctor. Because she is pregnant, they can't do an MRI and spinal tap until

6 weeks after the baby is born. But he told her that he is pretty sure that

is what she has...she has every symptom.

Anyone here that has it? She is 27 years old, and due with her second baby

in March. Any advice?

Betty

<HTML><!DOCTYPE html PUBLIC " -//W3C//DTD XHTML 1.0 Transitional//EN "

" HYPERLINK

" http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd " http://www.w3.org/T

R/xhtml1/DTD/xhtml1-transitional.dtd " ><BODY><FONT FACE= " monospace " SIZE= " 3 " >

<B>IMPORTANT ADDRESSES</B>

<UL>

<LI><B><A HREF= " HYPERLINK

" / " http://health.groups

../group/ / " >NATIVE NUTRITION</A></B> online</LI>

<LI><B><A HREF= " HYPERLINK

" http://onibasu.com/ " http://onibasu.com/ " >SEARCH</A></B> the entire message

archive with Onibasu</LI>

</UL></FONT>

<PRE><FONT FACE= " monospace " SIZE= " 3 " ><B><A

HREF= " mailto: -owner " >LIST OWNER:</A></B>

Idol

<B>MODERATORS:</B> Heidi Schuppenhauer

Wanita Sears

</FONT></PRE>

</BODY>

</HTML>

Link to comment
Share on other sites

Many MS symptoms improve on a gluten free diet. This is easy and safe

and cheap for her to try now. And if it is gluten related it will be all

the better for the child for her to be off gluten during the rest of her

pregnancy Read Dangerous Grains by Dr Braly. Come to GFCFNN for more

inofrmation

Ellen

On 2/8/06, Betty Pearson <betty@...> wrote:

>

> My oldest daughter has been diagnosed with Multiple Sclerosis. She had

> an

> appointment with her OB today, and he sent her straight over to another

> doctor. Because she is pregnant, they can't do an MRI and spinal tap

> until

> 6 weeks after the baby is born. But he told her that he is pretty sure

> that

> is what she has...she has every symptom.

>

> Anyone here that has it? She is 27 years old, and due with her second

> baby

> in March. Any advice?

>

> Betty

>

>

>

>

>

> <HTML><!DOCTYPE html PUBLIC " -//W3C//DTD XHTML 1.0 Transitional//EN " "

> http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd " ><BODY><FONT

> FACE= " monospace " SIZE= " 3 " >

> <B>IMPORTANT ADDRESSES</B>

> <UL>

> <LI><B><A

HREF= " / " >NATIVE

> NUTRITION</A></B> online</LI>

> <LI><B><A HREF= " http://onibasu.com/ " >SEARCH</A></B> the entire message

> archive with Onibasu</LI>

> </UL></FONT>

> <PRE><FONT FACE= " monospace " SIZE= " 3 " ><B><A HREF= " mailto:

> -owner " >LIST OWNER:</A></B> Idol

> <B>MODERATORS:</B> Heidi Schuppenhauer

> Wanita Sears

> </FONT></PRE>

> </BODY>

> </HTML>

>

>

>

>

Link to comment
Share on other sites

Hi Betty:

I just got back from a health conference in Seattle and although MS was not

discussed it detail it was suggested that MS is linked to lyme disease and

herpes.

It's worth checking out given MS and many other auto-immune disease continue

to confound the medical community.

vsp

On 2/8/06, Betty Pearson <betty@...> wrote:

>

> My oldest daughter has been diagnosed with Multiple Sclerosis. She had an

> appointment with her OB today, and he sent her straight over to another

> doctor. Because she is pregnant, they can't do an MRI and spinal tap

> until

> 6 weeks after the baby is born. But he told her that he is pretty sure

> that

> is what she has...she has every symptom.

>

> Anyone here that has it? She is 27 years old, and due with her second

> baby

> in March. Any advice?

>

> Betty

>

>

>

>

>

>

Link to comment
Share on other sites

Gluten MS search gives gluten and dairy thumbs down and animal protein thumbs

up.

Multiple Sclerosis and Dietary Intervention

http://paleodiet.com/ms/

Multiple Sclerosis News

http://www.jsumption.com/imssf/modules.php?op=modload & name=Sections & file=index & r\

eq=listarticles & secid=36

Brain Lesions Identical in MS and CD/gluten ataxia (from MS News)

http://tinyurl.com/doz97

Wanita

There are strong links between MS (and other auto-immune diseases) and diary

consumption, and yes raw milk is equally culprit, or more culprit in some

studies. There are also known links to high meat consumption. I personally

(through reading research) believe that it’s linkd to milk-protein (casein)

reactions (like allergic reactions, which are not always apparent to

people), at least in part, as this reaction is the kind that’s linked to

other auto-immune diseases, including diabetes, and chronic

inflammatory-related heart-disease. I’m not sure how the high-meat

consumption would fit in though, but imagnine it’d be similar to whatever

pathways cause the much higher cancer incidence in high-meat (and dairy)

consumers. Gluten intolerance may be anotoher link to MS. linda

Link to comment
Share on other sites

My dad was diagnosed with MS about 10 years ago. He could barely walk, talk,

hear, see. He didn't want to resign himself to a wheelchair and be dependent

on others. He tried a bunch of crazy " cures " . We finally figured out that he

had mercury poisoning. He replaced his fillings and did aggressive chelation

for a few years. His health improved dramatically. His doctors said he was

in " remission " . He never fully recovered (maybe 80-90% better) and he is

still doing detox, but he is happy that he found out about mercury.

His situation inspired me to create my site http://www.MDLies.com/

Bottom line: It's worthwhile exploring other things that can cause " MS-like "

symptoms. I think MS does exist, but there are a bunch of people that are

misdiagnosed.

Dan

http://www.HealthyPages.com/

> My oldest daughter has been diagnosed with Multiple

> Sclerosis. She had an

> appointment with her OB today, and he sent her straight over

> to another

> doctor. Because she is pregnant, they can't do an MRI and

> spinal tap until

> 6 weeks after the baby is born. But he told her that he is

> pretty sure that

> is what she has...she has every symptom.

Link to comment
Share on other sites

I just listened to the DVD by Dr. Canell about Vit D and MS. I would

order the CD or DVD from Pfeffer Productions Media Sales

PO BOX 1063

Bel Air, MD 21014

On Feb 7, 2006, at 11:16 PM, Betty Pearson wrote:

> My oldest daughter has been diagnosed with Multiple Sclerosis. She

> had an

> appointment with her OB today, and he sent her straight over to another

> doctor. Because she is pregnant, they can't do an MRI and spinal tap

> until

> 6 weeks after the baby is born. But he told her that he is pretty

> sure that

> is what she has...she has every symptom.

>

> Anyone here that has it? She is 27 years old, and due with her second

> baby

> in March. Any advice?

>

> Betty

Parashis

artpages@...

zine:

artpagesonline.com

portfolio:

http://www.artpagesonline.com/EPportfolio/000portfolio.html

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...